Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy

被引:0
|
作者
Francesco Testa
Paolo Melillo
Valentina Di Iorio
Claudio Iovino
Francesco Farinaro
Marianthi Karali
Sandro Banfi
Settimio Rossi
Michele Della Corte
Francesca Simonelli
机构
[1] University of Campania Luigi Vanvitelli,Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences
[2] University of Campania Luigi Vanvitelli,Medical Genetics, Department of Precision Medicine
[3] Telethon Institute of Genetics and Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
To report quantitative retinal changes assessed by spectral-domain optical coherence tomography (SD-OCT) in children treated with voretigene neparvovec (VN) at a single center in Italy. Retrospective review of six consecutive pediatric patients with biallelic RPE65-related dystrophy treated bilaterally with VN. SD-OCT scans were analyzed to extract Early Treatment Diabetic Retinopathy Study (ETDRS) thickness maps of the whole retina and the outer nuclear layer (ONL). Changes in visual function were assessed by best-corrected visual acuity (BCVA) and retinal morphology at Days 30/45 and 180. BCVA significantly improved at Day 30/45 and 6 months (both P < 0.001). Central foveal retinal thickness and central foveal ONL thickness tended to increase (6.4 ± 19.2 µm; P = 0.080 and 3.42 ± 7.68 µm; P = 0.091, respectively). ONL thickness of the internal ETDRS-ring significantly increased at day 30/45 (4.7 ± 8.4 µm; P < 0.001) and day 180 (5.0 ± 5.7 µm; P = 0.009). Intra-operative foveal detachment was not associated with a higher function gain in terms of BCVA, but with a mild thinning of foveal ONL after treatment. The improvement of BCVA and thickening of the ONL layer suggest that improvement of visual acuity could be related to partial recovery of retinal morphology in the perifoveal ring.
引用
收藏
相关论文
共 50 条
  • [1] Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
    Testa, Francesco
    Melillo, Paolo
    Di Iorio, Valentina
    Iovino, Claudio
    Farinaro, Francesco
    Karali, Marianthi
    Banfi, Sandro
    Rossi, Settimio
    Della Corte, Michele
    Simonelli, Francesca
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Results of Belgian patients with RPE65-related inherited retinal dystrophy 6 months after treatment with voretigene neparvovec
    Hertens, Leen
    Van Cauwenbergh, Caroline
    Van den Broeck, Filip
    Sambaer, Julie
    Van Haute, Manon
    Hertens, Pieter
    De Baere, Elfride
    Accou, Geraldine
    Nerinckx, Fanny
    Leroy, Bart Peter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy
    Kessel, Line
    Christensen, Ulrik Correll
    Klemp, Kristian
    OPHTHALMOLOGY, 2022, 129 (11) : 1287 - 1293
  • [4] Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
    Zimmermann, Marita
    Lubinga, Solomon J.
    Banken, Reiner
    Rind, David
    Cramer, Geri
    Synnott, Patricia G.
    Chapman, Richard H.
    Khan, Sonya
    Carlson, Josh
    VALUE IN HEALTH, 2019, 22 (02) : 161 - 167
  • [5] Chromatic pupillometry as an objective outcome to evaluate effects of Voretigene Neparvovec treatment in patients with RPE65-related inherited retinal dystrophies
    Testa, Francesco
    Melillo, Paolo
    Di Iorio, Valentina
    Citro, Amelia
    Rossi, Settimio
    Della Corte, MIchele
    Simonelli, Francesca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [6] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Viriato, Daniel
    Bennett, Natalie
    Sidhu, Raisa
    Hancock, Elizabeth
    Lomax, Hannah
    Trueman, David
    MacLaren, Robert E.
    ADVANCES IN THERAPY, 2020, 37 (03) : 1233 - 1247
  • [7] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Daniel Viriato
    Natalie Bennett
    Raisa Sidhu
    Elizabeth Hancock
    Hannah Lomax
    David Trueman
    Robert E. MacLaren
    Advances in Therapy, 2020, 37 : 1233 - 1247
  • [8] Voretigene neparvovec-rzyl for the treatment of biallelic RPE65 mutation-associated retinal dystrophy
    Russell, Stephen
    Bennett, Jean
    Maguire, Albert M.
    High, Katherine A.
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (08): : 457 - 464
  • [9] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Kang, Connie
    Scott, Lesley J.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (04) : 487 - 495
  • [10] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Connie Kang
    Lesley J. Scott
    Molecular Diagnosis & Therapy, 2020, 24 : 487 - 495